Our published data have shown that sGCα1 is an AR target gene that is over-expressed in prostate tumors at both the mRNA and protein levels, while expression of sGCβ1, its dimerization partner to form the sGC enzyme [14], is not significantly elevated [13]. The gene discussed is AR; the disease is prostate neoplasm.